Neurotransmitter influence on human meibomian gland epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 12, 2011, Pages 8543-8548

  Kam, Wendy R ^a   Sullivan, David A ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CALCIUM ION; CARBACHOL; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; MUSCARINIC RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; MEIBOMIAN GLAND; MEIBOMIAN GLAND EPITHELIAL CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA TRANSCRIPTION; RNA TRANSLATION;

1-METHYL-3-ISOBUTYLXANTHINE; ADENYLATE CYCLASE; CALCIUM; CARBACHOL; CELL DIVISION; CELL LINE, TRANSFORMED; CHOLINERGIC AGONISTS; EPITHELIAL CELLS; FORSKOLIN; HUMANS; MEIBOMIAN GLANDS; PARASYMPATHETIC FIBERS, POSTGANGLIONIC; PHOSPHODIESTERASE INHIBITORS; RECEPTORS, MUSCARINIC; VASOACTIVE INTESTINAL PEPTIDE;

EID: 80055119382     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8113     Document Type: Article

References (59)

1. McCulley JP, Shine WE. Meibomian gland function and the tear lipid layer. Ocul Surf. 2003;1:97-106.
2. Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp Eye Res. 2004;78:347-360.
3. 2007 Report of the Dry Eye WorkShop. Ocul Surf. 2007;5:65-204.
4. Knop E, Knop N, Millar T, Obata H, Sullivan DA. The International Workshop on Meibomian Gland Dysfunction: report of the Subcommittee on Anatomy, Physiology, and Pathophysiology of the Meibomian Gland. Invest Ophthalmol Vis Sci. 2011;52:1938-1978.
5. Craig JP, Tomlinson A. Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci. 1997;74:8-13.
6. Driver PJ, Lemp MA. Meibomian gland dysfunction. Surv Ophthalmol. 1996;40:343-367.
7. Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf. 2003;1:107-126.
8. Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf. 2009;7:S1-S14.
9. Mathers W. Evaporation from the ocular surface. Exp Eye Res. 2004;78:389-394.
10. Green-Church KB, Butovich I, Willcox M, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease. Invest Ophthalmol Vis Sci. 2011;52:1979-1993.
11. Horwath-Winter J, Berghold A, Schmut O, et al. Evaluation of the clinical course of dry eye syndrome. Arch Ophthalmol. 2003;121: 1364-1368.
12. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52:1930-1937.
13. Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci. 2011;52: 1994-2005.
14. Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol. 1995;113:1266-1270.
15. Thody AJ, Shuster S. Control and function of sebaceous glands. Physiol Rev. 1989;69:383-416.
16. Aisa J, Lahoz M, Serrano P, et al. Acetylcholinesterase-positive and paraformaldehyde-induced-fluorescence-positive innervation in the upper eyelid of the sheep (Ovis aries). Histol Histopathol. 2001;16:487-496.
17. Chanthaphavong RS, Murphy SM, Anderson CR. Chemical coding of sympathetic neurons controlling the tarsal muscle of the rat. Auton Neurosci. 2003;105:77-89.
18. Chung CW, Tigges M, Stone RA. Peptidergic innervation of the primate meibomian gland. Invest Ophthalmol Vis Sci. 1996;37: 238-245.
19. Fan Q, Smith PG. Decreased vasoactive intestinal polypeptideimmunoreactivity of parasympathetic neurons and target innervation following long-term sympathectomy. Regul Pept. 1993;48: 337-343.
20. Hartschuh W, Reinecke M, Weihe E, Yanaihara N. VIP-immunoreactivity in the skin of various mammals: immunohistochemical, radioimmunological and experimental evidence for a dual localization in cutaneous nerves and merkel cells. Peptides. 1984;5:239-245.
21. Kirch W, Horneber M, Tamm ER. Characterization of Meibomian gland innervation in the cynomolgus monkey (Macaca fascicularis). Anat Embryol (Berl). 1996;193:365-375.
22. LeDoux MS, Zhou Q, Murphy RB, Greene ML, Ryan P. Parasympathetic innervation of the meibomian glands in rats. Invest Ophthalmol Vis Sci. 2001;42:2434-2441.
23. Lorber M. Somatostatin-like immunoreactivity (SLIR) in rat harderian and meibomian glands and glands of Zeis. Adv Exp Med Biol. 2002;506:81-89.
24. Luhtala J, Palkama A, Uusitalo H. Calcitonin gene-related peptide immunoreactive nerve fibers in the rat conjunctiva. Invest Ophthalmol Vis Sci. 1991;32:640-645.
25. Luhtala J, Uusitalo H. The distribution and origin of substance P immunoreactive nerve fibres in the rat conjunctiva. Exp Eye Res. 1991;53:641-646.
26. Montagna W, Ellis RA. Cholinergic innervation of the Meibomian glands. Anat Rec. 1959;135:121-127.
27. Perra MT, Serra A, Sirigu P, Turno F. Histochemical demonstration of acetylcholinesterase activity in human Meibomian glands. Eur J Histochem. 1996;40:39-44.
28. Seifert P, Spitznas M. Immunocytochemical and ultrastructural evaluation of the distribution of nervous tissue and neuropeptides in the meibomian gland. Graefes Arch Clin Exp Ophthalmol. 1996;234:648-656.
29. Seifert P, Spitznas M. Vasoactive intestinal polypeptide (VIP) innervation of the human eyelid glands. Exp Eye Res. 1999;68:685-692.
30. Simons E, Smith PG. Sensory and autonomic innervation of the rat eyelid: neuronal origins and peptide phenotypes. J Chem Neuroanat. 1994;7:35-47.
31. Smith PG, Reddy H. Reorganization of cranial sympathetic pathways following neonatal ganglionectomy in the rat. J Comp Neurol. 1990;301:490-500.
32. Sokolov VE, Shabadash SA, Zelikina TI. Innervation of specific skin glands in the rabbit: the cholinergic terminal reticulum [in Russian]. Dokl Akad Nauk SSSR. 1984;277:1245-1249.
33. Schirra F, Suzuki T, Richards SM, et al. Androgen control of gene expression in the mouse meibomian gland. Invest Ophthalmol Vis Sci. 2005;46:3666-3675.
34. Liu S, Hatton MP, Khandelwal P, Sullivan DA. Culture, immortalization, and characterization of human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2010;51:3993-4005.
35. Dickson L, Finlayson K. VPAC and PAC receptors: from ligands to function. Pharmacol Ther. 2009;121:294-316.
36. Andersson KE. Muscarinic acetylcholine receptors in the urinary tract. Handb Exp Pharmacol. 2011;319-344.
37. Seamon KB, Padgett W, Daly JW. Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci U S A. 1981;78:3363-3367.
38. Spina D. PDE4 inhibitors: current status. Br J Pharmacol. 2008; 155:308-315.
39. Zhu HY, Riau AK, Barathi VA, Chew J, Beuerman RW. Expression of neural receptors in mouse meibomian gland. Cornea. 2010;29: 794-801.
40. Liu S, Li J, Tan DT, Beuerman RW. The eyelid margin: a transitional zone for 2 epithelial phenotypes. Arch Ophthalmol. 2007;125: 523-532.
41. Arrighi N, Bodei S, Peroni A, et al. Detection of muscarinic receptor subtypes in human urinary bladder mucosa: age and genderdependent modifications. Neurourol Urodyn. 2008;27:421-428.
42. Boige N, Amiranoff B, Munck A, Laburthe M. Forskolin stimulates adenylate cyclase in human colonic crypts: interaction with VIP. Eur J Pharmacol. 1984;101:111-117.
43. Fukayama S, Tashjian AH Jr, Bringhurst FR. Forskolin-induced homologous desensitization via an adenosine 3_,5_-monophosphatedependent mechanism(s) in human osteoblast-like SaOS-2 cells. Endocrinology. 1992;131:1770-1776.
44. Guild S, Drummond AH. Vasoactive-intestinal-polypeptide-stimulated adenosine 3_,5_-cyclic monophosphate accumulation in GH3 pituitary tumour cells. Reversal of desensitization by forskolin. Biochem J. 1984;221:789-796.
45. Mauduit P, Herman G, Rossignol B. Newly synthesized protein secretion in rat lacrimal gland: post-second messenger synergism. Am J Physiol. 1987;253:C514-C524.
46. Sato K, Sato F. Effect of VIP on sweat secretion and cAMP accumulation in isolated simian eccrine glands. Am J Physiol. 1987; 253:R935-R941.
47. Laburthe M, Rousset M, Boissard C, Chevalier G, Zweibaum A, Rosselin G. Vasoactive intestinal peptide: a potent stimulator of adenosine 3_:5_-cyclic monophosphate accumulation in gut carcinoma cell lines in culture. Proc Natl Acad Sci U S A. 1978;75: 2772-2775.
48. Sreedharan SP, Patel DR, Xia M, Ichikawa S, Goetzl EJ. Human vasoactive intestinal peptide1 receptors expressed by stable transfectants couple to two distinct signaling pathways. Biochem Biophys Res Commun. 1994;203:141-148.
49. Luo X, Zeng W, Xu X, et al. Alternate coupling of receptors to Gs and Gi in pancreatic and submandibular gland cells. J Biol Chem. 1999;274:17684-17690.
50. Yoshimura K, Nezu E. Interaction between the calcium and cyclic AMP messenger systems in perifused rat parotid acinar cells. Possible mechanism for potentiation of amylase secretion. Biochem Pharmacol. 1992;43:1031-1041.
51. Sirigu P, Shen RL, Pinto da Silva P. Human meibomian glands: the ultrastructure of acinar cells as viewed by thin section and freezefracture transmission electron microscopies. Invest Ophthalmol Vis Sci. 1992;33:2284-2292.
52. Olami Y, Zajicek G, Cogan M, Gnessin H, Pe'er J. Turnover and migration of meibomian gland cells in rats' eyelids. Ophthalmic Res. 2001;33:170-175.
53. Hodges RR, Dartt DA. Regulatory pathways in lacrimal gland epithelium. Int Rev Cytol. 2003;231:129-196.
54. Hodges RR, Dicker DM, Rose PE, Dartt DA. Alpha 1-adrenergic and cholinergic agonists use separate signal transduction pathways in lacrimal gland. Am J Physiol. 1992;262:G1087-G1096.
55. Dursun D, Wang M, Monroy D, et al. A mouse model of keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci. 2002;43:632-638.
56. Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol. 2008;126:219-225.
57. El Annan J, Chauhan SK, Ecoiffier T, Zhang Q, Saban DR, Dana R. Characterization of effector T cells in dry eye disease. Invest Ophthalmol Vis Sci. 2009;50:3802-3807.
58. Scifo C, Barabino S, De Pasquale G, Blanco AR, Mazzone MG, Rolando M. Effects of a new lipid tear substitute in a mouse model of dry eye. Cornea. 2010;29:802-806.
59. Wei Y, Epstein SP, Fukuoka S, Birmingham NP, Li XM, Asbell PA. sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model. Invest Ophthalmol Vis Sci. 2011;52:4780-4788.